Showing results (481-490 of 1,128) with videos related to

Sort By:
Pageof 113
Biochemical and Biophysical Research Communications|April 14, 1987
Isolation and sequence of a cDNA clone for the rat pulmonary surfactant-associated protein (PSP-A)K Sano, J Fisher, R J Mason, et al.
Investigational New Drugs|November 1, 1990
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group studyH I Robins, D S Neuberg, A B Benson, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|August 30, 2017
Ectopic Intrathyroidal Thymic Tissue Mimicking Thyroid Nodules in ChildrenMary C Frates, Carol B Benson, David M Dorfman, et al.
Fertility and Sterility|December 1, 1993
The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized studyE S Ginsburg, C B Benson, J M Garfield, et al.
American Journal of Clinical Oncology|February 22, 2000
Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293)R F Asbury, S Lipsitz, D Graham, et al.
Journal of Clinical Ultrasound : JCU|March 4, 2014
Testicular microlithiasis: prevalence and association with primary testicular neoplasmHoward T Heller, Matthew C Oliff, Peter M Doubilet, et al.
Cancer|November 1, 1984
Transient neurologic dysfunction following moderate-dose methotrexate for undifferentiated lymphomaR L Martino, A B Benson, J A Merritt, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trialsM Extermann, M Bonetti, G W Sledge, et al.
Journal of Medical Economics|June 1, 2017
Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LARLynn Huynh, Todor Totev, Francis Vekeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203Weijing Sun, Mark Powell, Peter J O'Dwyer, et al.
Pageof 113